Chartwell Pharmaceuticals is now a registered pharmaceutical manufacturer with the FDA, effective March 15, 2011. The registration marks the company’s process of restructuring and expanding in the generic pharmaceuticals market. Kimberly Ezdebski, Chartwell’s senior director of Quality and Regulatory, said, “Chartwell has all the quality systems (as outlined in the Code of Federal Regulations) and GMPs in place that are mandated to be registered with the FDA. We are confident that b...